• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与癌症相关的剪接因子CAPERα在特定三元复合物中与必需剪接因子SF3b155结合。

Cancer-relevant splicing factor CAPERα engages the essential splicing factor SF3b155 in a specific ternary complex.

作者信息

Loerch Sarah, Maucuer Alexandre, Manceau Valérie, Green Michael R, Kielkopf Clara L

机构信息

From the Department of Biochemistry and Biophysics, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642 and.

the Howard Hughes Medical Institute and Programs in Gene Function and Expression and Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605

出版信息

J Biol Chem. 2014 Jun 20;289(25):17325-37. doi: 10.1074/jbc.M114.558825. Epub 2014 May 2.

DOI:10.1074/jbc.M114.558825
PMID:24795046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4067167/
Abstract

U2AF homology motifs (UHMs) mediate protein-protein interactions with U2AF ligand motifs (ULMs) of pre-mRNA splicing factors. The UHM-containing alternative splicing factor CAPERα regulates splicing of tumor-promoting VEGF isoforms, yet the molecular target of the CAPERα UHM is unknown. Here we present structures of the CAPERα UHM bound to a representative SF3b155 ULM at 1.7 Å resolution and, for comparison, in the absence of ligand at 2.2 Å resolution. The prototypical UHM/ULM interactions authenticate CAPERα as a bona fide member of the UHM family of proteins. We identify SF3b155 as the relevant ULM-containing partner of full-length CAPERα in human cell extracts. Isothermal titration calorimetry comparisons of the purified CAPERα UHM binding known ULM-containing proteins demonstrate that high affinity interactions depend on the presence of an intact, intrinsically unstructured SF3b155 domain containing seven ULM-like motifs. The interplay among bound CAPERα molecules gives rise to the appearance of two high affinity sites in the SF3b155 ULM-containing domain. In conjunction with the previously identified, UHM/ULM-mediated complexes of U2AF(65) and SPF45 with SF3b155, this work demonstrates the capacity of SF3b155 to offer a platform for coordinated recruitment of UHM-containing splicing factors.

摘要

U2AF同源基序(UHMs)介导与前体mRNA剪接因子的U2AF配体基序(ULMs)的蛋白质-蛋白质相互作用。含UHM的可变剪接因子Caperα调节促肿瘤血管内皮生长因子(VEGF)异构体的剪接,但Caperα UHM的分子靶点尚不清楚。在此,我们展示了Caperα UHM与代表性的SF3b155 ULM结合时分辨率为1.7 Å的结构,作为比较,还展示了其在无配体时分辨率为2.2 Å的结构。典型的UHM/ULM相互作用证实Caperα是UHM家族蛋白质的真正成员。我们在人细胞提取物中确定SF3b155是全长Caperα的相关含ULM的伙伴。对纯化的Caperα UHM与已知含ULM蛋白质结合的等温滴定量热法比较表明,高亲和力相互作用取决于完整的、内在无序的含有七个ULM样基序的SF3b155结构域的存在。结合的Caperα分子之间的相互作用导致在含SF3b155 ULM的结构域中出现两个高亲和力位点。结合先前鉴定的U2AF(65)和SPF45与SF3b155的UHM/ULM介导的复合物,这项工作证明了SF3b155为协调招募含UHM的剪接因子提供平台的能力。

相似文献

1
Cancer-relevant splicing factor CAPERα engages the essential splicing factor SF3b155 in a specific ternary complex.与癌症相关的剪接因子CAPERα在特定三元复合物中与必需剪接因子SF3b155结合。
J Biol Chem. 2014 Jun 20;289(25):17325-37. doi: 10.1074/jbc.M114.558825. Epub 2014 May 2.
2
U2AF-homology motif interactions are required for alternative splicing regulation by SPF45.SPF45进行可变剪接调控需要U2AF同源基序相互作用。
Nat Struct Mol Biol. 2007 Jul;14(7):620-9. doi: 10.1038/nsmb1260. Epub 2007 Jun 24.
3
Dimerization and protein binding specificity of the U2AF homology motif of the splicing factor Puf60.剪接因子Puf60的U2AF同源基序的二聚化及蛋白质结合特异性
J Biol Chem. 2009 Jan 2;284(1):630-639. doi: 10.1074/jbc.M805395200. Epub 2008 Oct 29.
4
UHM-ULM interactions in the RBM39-U2AF65 splicing-factor complex.RBM39-U2AF65剪接因子复合物中的UHM-ULM相互作用。
Acta Crystallogr D Struct Biol. 2016 Apr;72(Pt 4):497-511. doi: 10.1107/S2059798316001248. Epub 2016 Mar 24.
5
Multiple U2AF65 binding sites within SF3b155: thermodynamic and spectroscopic characterization of protein-protein interactions among pre-mRNA splicing factors.SF3b155内多个U2AF65结合位点:前体mRNA剪接因子间蛋白质-蛋白质相互作用的热力学和光谱学特征
J Mol Biol. 2006 Feb 24;356(3):664-83. doi: 10.1016/j.jmb.2005.11.067. Epub 2005 Dec 7.
6
U2AF assemblies drive sequence-specific splice site recognition.U2AF 组装体驱动序列特异性剪接位点识别。
EMBO Rep. 2019 Aug;20(8):e47604. doi: 10.15252/embr.201847604. Epub 2019 Jul 4.
7
The pre-mRNA splicing and transcription factor Tat-SF1 is a functional partner of the spliceosome SF3b1 subunit via a U2AF homology motif interface.前体 mRNA 剪接和转录因子 Tat-SF1 通过 U2AF 同源基序界面与剪接体 SF3b1 亚基形成功能伙伴关系。
J Biol Chem. 2019 Feb 22;294(8):2892-2902. doi: 10.1074/jbc.RA118.006764. Epub 2018 Dec 19.
8
The SF3b155 N-terminal domain is a scaffold important for splicing.SF3b155 N 端结构域是剪接过程中一个重要的支架。
Biochemistry. 2006 Aug 22;45(33):10092-101. doi: 10.1021/bi060429o.
9
Cus2 enforces the first ATP-dependent step of splicing by binding to yeast SF3b1 through a UHM-ULM interaction.Cus2 通过与酵母 SF3b1 结合,通过 UHM-ULM 相互作用来强制剪接的第一个 ATP 依赖性步骤。
RNA. 2019 Aug;25(8):1020-1037. doi: 10.1261/rna.070649.119. Epub 2019 May 20.
10
Biochemical and NMR analyses of an SF3b155-p14-U2AF-RNA interaction network involved in branch point definition during pre-mRNA splicing.参与前体mRNA剪接过程中分支点定义的SF3b155-p14-U2AF-RNA相互作用网络的生化与核磁共振分析。
RNA. 2006 Mar;12(3):410-25. doi: 10.1261/rna.2271406.

引用本文的文献

1
A Paired Database of Predicted and Experimental Protein Peptide Binding Information.一个预测性与实验性蛋白质肽结合信息的配对数据库。
Sci Data. 2025 Aug 20;12(1):1455. doi: 10.1038/s41597-025-05754-7.
2
RNA-coupled CRISPR Screens Reveal ZNF207 as a Regulator of LMNA Aberrant Splicing in Progeria.RNA偶联的CRISPR筛选揭示ZNF207是早衰症中LMNA异常剪接的调节因子。
bioRxiv. 2025 Apr 26:2025.04.25.648738. doi: 10.1101/2025.04.25.648738.
3
Recent advances in anticancer mechanisms of molecular glue degraders: focus on RBM39-dgrading synthetic sulfonamide such as indisulam, E7820, tasisulam, and chloroquinoxaline sulfonamide.近年来分子连接酶降解剂抗癌机制的研究进展:聚焦于 RBM39 降解的合成磺胺类药物,如依达司他、E7820、他昔舒仑和氯喹喔啉磺胺类药物。
Genes Genomics. 2024 Dec;46(12):1345-1361. doi: 10.1007/s13258-024-01565-z. Epub 2024 Sep 13.
4
Branch site recognition by the spliceosome.剪接体对分支位点的识别。
RNA. 2024 Oct 16;30(11):1397-1407. doi: 10.1261/rna.080198.124.
5
Molecular basis of RNA-binding and autoregulation by the cancer-associated splicing factor RBM39.癌症相关剪接因子 RBM39 的 RNA 结合和自身调控的分子基础。
Nat Commun. 2023 Sep 4;14(1):5366. doi: 10.1038/s41467-023-40254-5.
6
Pre-mRNA splicing-associated diseases and therapies.前体 mRNA 剪接相关疾病和治疗方法。
RNA Biol. 2023 Jan;20(1):525-538. doi: 10.1080/15476286.2023.2239601.
7
Therapeutic Targeting of RNA Splicing in Cancer.癌症中 RNA 剪接的治疗靶向。
Genes (Basel). 2023 Jun 29;14(7):1378. doi: 10.3390/genes14071378.
8
RNA splicing dysregulation and the hallmarks of cancer.RNA 剪接失调与癌症的特征。
Nat Rev Cancer. 2023 Mar;23(3):135-155. doi: 10.1038/s41568-022-00541-7. Epub 2023 Jan 10.
9
RNA binding proteins in MLL-rearranged leukemia.MLL重排白血病中的RNA结合蛋白
Exp Hematol Oncol. 2022 Oct 28;11(1):80. doi: 10.1186/s40164-022-00343-5.
10
Systematic pan-cancer analysis identifies RBM39 as an immunological and prognostic biomarker.系统泛癌症分析确定 RBM39 为免疫和预后生物标志物。
J Cell Mol Med. 2022 Sep;26(18):4859-4871. doi: 10.1111/jcmm.17517. Epub 2022 Aug 21.

本文引用的文献

1
Analysis Tool Web Services from the EMBL-EBI.EMBL-EBI 的分析工具 Web 服务。
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W597-600. doi: 10.1093/nar/gkt376. Epub 2013 May 13.
2
SF3B1 mutations in chronic lymphocytic leukemia.SF3B1 突变与慢性淋巴细胞白血病。
Blood. 2013 Jun 6;121(23):4627-34. doi: 10.1182/blood-2013-02-427641. Epub 2013 Apr 8.
3
Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma.眼黑色素瘤中剪接因子 SF3B1 密码子 625 位的反复突变。
Nat Genet. 2013 Feb;45(2):133-5. doi: 10.1038/ng.2523. Epub 2013 Jan 13.
4
Structure of phosphorylated SF1 bound to U2AF⁶⁵ in an essential splicing factor complex.磷酸化 SF1 与 U2AF⁶⁵ 结合形成必需剪接因子复合物的结构。
Structure. 2013 Feb 5;21(2):197-208. doi: 10.1016/j.str.2012.10.020. Epub 2012 Dec 27.
5
Structure, phosphorylation and U2AF65 binding of the N-terminal domain of splicing factor 1 during 3'-splice site recognition.剪接因子 1 的 N 端结构域在识别 3' 剪接位点时的磷酸化和 U2AF65 结合
Nucleic Acids Res. 2013 Jan;41(2):1343-54. doi: 10.1093/nar/gks1097. Epub 2012 Nov 21.
6
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.胰腺癌基因组揭示了神经导向途径基因的异常。
Nature. 2012 Nov 15;491(7424):399-405. doi: 10.1038/nature11547. Epub 2012 Oct 24.
7
Comprehensive molecular portraits of human breast tumours.人类乳腺肿瘤的全面分子特征图谱。
Nature. 2012 Oct 4;490(7418):61-70. doi: 10.1038/nature11412. Epub 2012 Sep 23.
8
The development and application of small molecule modulators of SF3b as therapeutic agents for cancer.SF3b 小分子调节剂的开发和应用作为癌症的治疗药物。
Drug Discov Today. 2013 Jan;18(1-2):43-9. doi: 10.1016/j.drudis.2012.07.013. Epub 2012 Aug 3.
9
Size-exclusion chromatography in structural analysis of intrinsically disordered proteins.尺寸排阻色谱法在内在无序蛋白质结构分析中的应用
Methods Mol Biol. 2012;896:179-94. doi: 10.1007/978-1-4614-3704-8_11.
10
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.骨髓增生异常综合征中 U2AF1 剪接因子的反复突变。
Nat Genet. 2011 Dec 11;44(1):53-7. doi: 10.1038/ng.1031.